| pubmed-article:14523056 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14523056 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:14523056 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:14523056 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
| pubmed-article:14523056 | lifeskim:mentions | umls-concept:C0494165 | lld:lifeskim |
| pubmed-article:14523056 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:14523056 | lifeskim:mentions | umls-concept:C0021439 | lld:lifeskim |
| pubmed-article:14523056 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:14523056 | pubmed:dateCreated | 2003-10-2 | lld:pubmed |
| pubmed-article:14523056 | pubmed:abstractText | Hepatic intra-arterial infusion chemotherapy of 5-fluorouracil (5-FU) or fluorodeoxyuridine (FUDR) has been a treatment option for liver metastasis from colorectal cancer. However, an optimal administration schedule of 5-FU is still controversial. This study was conducted to evaluate a suitable schedule from the viewpoint of 5-FU metabolites and related enzymes. | lld:pubmed |
| pubmed-article:14523056 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14523056 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14523056 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14523056 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14523056 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14523056 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14523056 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14523056 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:14523056 | pubmed:issn | 0368-2811 | lld:pubmed |
| pubmed-article:14523056 | pubmed:author | pubmed-author:NakamuraTomok... | lld:pubmed |
| pubmed-article:14523056 | pubmed:author | pubmed-author:YasudaSeieiS | lld:pubmed |
| pubmed-article:14523056 | pubmed:author | pubmed-author:SadahiroSotar... | lld:pubmed |
| pubmed-article:14523056 | pubmed:author | pubmed-author:MakuuchiHiroy... | lld:pubmed |
| pubmed-article:14523056 | pubmed:author | pubmed-author:SuzukiToshiyu... | lld:pubmed |
| pubmed-article:14523056 | pubmed:author | pubmed-author:TanakaYoichiY | lld:pubmed |
| pubmed-article:14523056 | pubmed:author | pubmed-author:IshikawaKenji... | lld:pubmed |
| pubmed-article:14523056 | pubmed:author | pubmed-author:MurayamaChiek... | lld:pubmed |
| pubmed-article:14523056 | pubmed:author | pubmed-author:MasudaTakahis... | lld:pubmed |
| pubmed-article:14523056 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14523056 | pubmed:volume | 33 | lld:pubmed |
| pubmed-article:14523056 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14523056 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14523056 | pubmed:pagination | 377-81 | lld:pubmed |
| pubmed-article:14523056 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:meshHeading | pubmed-meshheading:14523056... | lld:pubmed |
| pubmed-article:14523056 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14523056 | pubmed:articleTitle | Pharmacokinetics of 5-fluorouracil following hepatic intra-arterial infusion in a VX2 hepatic metastasis model. | lld:pubmed |
| pubmed-article:14523056 | pubmed:affiliation | Department of Surgery, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa, Japan. sadahiro@is.icc.u-tokai.ac.jp | lld:pubmed |
| pubmed-article:14523056 | pubmed:publicationType | Journal Article | lld:pubmed |
